Regeneron Pharmaceuticals, Inc. (REGN)
810.73
-4.06
(-0.50%)
USD |
NASDAQ |
Aug 27, 14:28
Regeneron Pharmaceuticals EPS Diluted (TTM) : 40.46 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 40.46 |
| March 31, 2026 | 41.04 |
| December 31, 2025 | 41.56 |
| September 30, 2025 | 41.77 |
| June 30, 2025 | 39.69 |
| March 31, 2025 | 39.29 |
| December 31, 2024 | 38.29 |
| September 30, 2024 | 40.41 |
| June 30, 2024 | 37.76 |
| March 31, 2024 | 33.85 |
| December 31, 2023 | 34.75 |
| September 30, 2023 | 35.06 |
| June 30, 2023 | 37.84 |
| March 31, 2023 | 36.81 |
| December 31, 2022 | 38.25 |
| September 30, 2022 | 47.44 |
| June 30, 2022 | 50.10 |
| March 31, 2022 | 70.60 |
| December 31, 2021 | 72.08 |
| September 30, 2021 | 62.63 |
| June 30, 2021 | 55.70 |
| March 31, 2021 | 35.34 |
| December 31, 2020 | 30.68 |
| September 30, 2020 | 27.36 |
| June 30, 2020 | 25.83 |
| Date | Value |
|---|---|
| March 31, 2020 | 19.91 |
| December 31, 2019 | 18.47 |
| September 30, 2019 | 18.69 |
| June 30, 2019 | 18.00 |
| March 31, 2019 | 21.13 |
| December 31, 2018 | 21.30 |
| September 30, 2018 | 15.65 |
| June 30, 2018 | 13.80 |
| March 31, 2018 | 12.32 |
| December 31, 2017 | 10.32 |
| September 30, 2017 | 11.01 |
| June 30, 2017 | 9.96 |
| March 31, 2017 | 8.31 |
| December 31, 2016 | 7.74 |
| September 30, 2016 | 6.89 |
| June 30, 2016 | 6.44 |
| March 31, 2016 | 6.44 |
| December 31, 2015 | 5.51 |
| September 30, 2015 | 5.13 |
| June 30, 2015 | 4.01 |
| March 31, 2015 | 3.14 |
| December 31, 2014 | 3.06 |
| September 30, 2014 | 2.837 |
| June 30, 2014 | 3.387 |
| March 31, 2014 | 3.357 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 5.923 |
| Gilead Sciences, Inc. | -2.656 |
| AbbVie, Inc. | 3.537 |
| Vertex Pharmaceuticals, Inc. | 17.19 |
| Amgen, Inc. | 16.10 |